Ipatasertib dihydrochloride New
Data Sheet
For research use only. Not for human use.
Get Quotation Now* Required Fields.
Please complete the form below and you will get the price list in 1 minute.
* Required Fields.
Please complete the form below and we will contact you shortly.
* Required Fields.
Please complete the form below and we will contact you shortly.
| CAS No. | 1396257-94-5 | Cat. No. | BCP23821 |
| Name | Ipatasertib dihydrochloride | ||
| Synonyms | GDC0068 2HCl;Ipatasertib 2HCl;GDC0068 dihydrochloride;GDC-0068 dihydrochloride; RG-7440 dihydrochloride; | ||
| SMILES | CC1CC(C2=C1C(=NC=N2)N3CCN(CC3)C(=O)C(CNC(C)C)C4=CC=C(C=C4)Cl)O.Cl.Cl | ||
| Chemical Name | |||
| Formula | C24H34Cl3N5O2 | M. Wt | 530.92 |
| Purity | 98% | Storage | Store at 4-8°C |
| Description | Ipatasertib is typically efficacious in xenograft models in which Akt is activated because of genetic alterations including PTEN loss, PIK3CA mutations/amplifications, or HER2 overexpression. In these models, tumor growth delay, stasis, or regression is achieved at or below 100 mg/kg daily oral dose, which is the maximum dose tested in immunocompromised mice that is well tolerated. When tested in vivo, daily dosing of Ipatasertib in combination with Docetaxel induces tumor regression and stasis in the PC-3 and MCF7-neo/HER2 xenograft models, at doses where each single agent is ineffective or only causes modest tumor growth delay. Similarly, increased TGI is observed in the OVCAR3 ovarian cancer xenograft model when Ipatasertib is combined with Carboplatin. The combination of Ipatasertib with Docetaxel or Carboplatin is tolerated with less than 5% body weight loss when compared with treatment with each chemotherapeutic agent alone. | ||
Recommend Products
More >
-
Solenopsin HCl
Cat. No.：BCP49141
No.：137119-46-1
Product Details -
Solenopsin
Cat. No.：BCP48761
No.：137038-57-4
Product Details -
ONC-201 Dihydrochloride
Cat. No.：BCP46830
No.：1638178-82-1
Product Details -
(E)-Akt inhibitor-IV
Cat. No.：BCP46776
No.：959841-49-7
Product Details -
A674563 HCl
Cat. No.：BCP46680
No.：A674563HCl
Product Details -
Borussertib
Cat. No.：BCP43065
No.：1800070-77-2
Product Details -
-
Merck-22-6
Cat. No.：BCP36078
No.：612847-42-4
Product Details -
-
Recilisib sodium
Cat. No.：BCP35048
No.：922139-31-9
Product Details -
E-Guggulsterone
Cat. No.：BCP34834
No.：39025-24-6
Product Details -
-
AT7867 dihydrochloride
Cat. No.：BCP30936
No.：1431697-86-7
Product Details -
-
Miransertib HCl
Cat. No.：BCP25709
No.：1313883-00-9
Product Details -
-
-
-
Akt Inhibitor IV
Cat. No.：BCP22722
No.：681281-88-9
Product Details -
(Z)-Guggulsterone
Cat. No.：BCP07472
No.：39025-23-5
Product Details
Tags:Ipatasertib dihydrochloride supplier,Ipatasertib dihydrochloride purchase,Ipatasertib dihydrochloride manufacturer,Ipatasertib dihydrochloride distributor,Ipatasertib dihydrochloride cost,Ipatasertib dihydrochloride buy,Ipatasertib dihydrochloride for sale